MBG/ PGA-PCL composite scaffolds provide highly tunable degradation and osteogenic features
Source abstract
Abstract
It remains a challenge to achieve satisfactory balance between biodegradability and osteogenic capacity in biosynthetic bone grafts. In this study, we aimed to address this challenge by incorporating mesoporous bioactive glass (MBG) into poly(caprolactone-co-glycolide) (PGA-PCL) at gradient ratios. MBG/PGA-PCL (PGC/M) scaffolds with MBG incorporation ratio at 0, 10%, 25% and 40% (PGC/M0-40) were synthesized using a modified solvent casting-particulate leaching method, and their physiochemical and biological properties were comprehensively evaluated. PGC/M scaffolds exhibited highly perforated porous structure with a large-pore size of 300-450 μm, with ordered MBGs of around 6.0 nm mesopores size uniformly dispersed. The increase in MBG incorporation ratio significantly improved the scaffold surface hydrophilicity, apatite-formation ability and pH stability, increased the weight loss rate while insignificantly influenced the molecular chains degradation of PGA-PCL component, and facilitated the attachment, spreading, viability and proliferation of rat bone marrow stromal cells (rBMSCs) on scaffolds. Moreover, rBMSCs cultured on PGC/M10-40 scaffolds demonstrated enhanced ALP activity and osteogenesis-related gene expression in a MBG dose-dependent manner as compared with those cultured on PGC/M0 scaffolds. When implanted to the rat cranial bone defect, PGC/M25 and PGC/M40 scaffolds induced significantly better bone repair as compared to PGC/M0 and PGC/M10 scaffolds. Besides, the biodegradability of PGC/M scaffolds correlated with the MBG incorporation ratio. These data suggested this novel PGC/M scaffolds as promising bone repair biomaterial with highly tunable hydrophilicity, bioactivity, cytocompatibility, osteogenic activity as well as biodegradability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Strategies for stimulation of new bone formation: a critical review10.1590/S0103-64402011000600001 ↗
2. In vitro and in vivo bone formation potential of surface calcium phosphate-coated polycaprolactone and polycaprolactone/bioactive glass composite scaffolds10.1016/j.actbio.2015.11.012 ↗
3. Biomimetic porous scaffolds for bone tissue engineering10.1016/j.mser.2014.04.001 ↗
4. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
5. Bone grafts and bone graft substitutes in orthopaedic trauma surgery10.2106/00004623-200703000-00026 ↗
6. Biodegradable synthetic polymers for tissue engineering10.22203/eCM.v005a01 ↗
7. Polylactide/polyglycolide copolymer in bone defect healing in humans10.1016/j.biomaterials.2007.12.034 ↗
8. Synthesis of bioresorbable polymers for medical applications
9. Synthetic biodegradable medical polymers: polymer blends
10. Mesoporous bioactive glass surface modified poly(lactic-co-glycolic acid) electrospun fibrous scaffold for bone regeneration
11. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(dl-lactide-co-glycolide) films10.1016/j.biomaterials.2009.01.029 ↗
12. Preparation and characterization of mesoporous bioactive glass/polycaprolactone nanofibrous matrix for bone tissues engineering10.1007/s10856-012-4734-z ↗
13. Preparation and characterization of bioactive mesoporous wollastonite - polycaprolactone composite scaffold10.1016/j.biomaterials.2008.10.046 ↗
14. A biodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering10.1016/j.bone.2009.09.031 ↗
15. PH-dependent antibacterial effects on oral microorganisms through pure PLGA implants and composites with nanosized bioactive glass10.1016/j.actbio.2013.06.030 ↗
16. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams
17. Fabrication of nanocrystalline hydroxyapatite doped degradable composite hollow fiber for guided and biomimetic bone tissue engineering10.1016/j.msec.2006.05.024 ↗
18. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide)
19. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering10.1016/j.actbio.2008.07.019 ↗
20. PEGylated poly(glycerol sebacate)-modified calcium phosphate scaffolds with desirable mechanical behavior and enhanced osteogenic capacity10.1016/j.actbio.2016.08.023 ↗
21. PLGA/β-TCP composite scaffold incorporating salvianolic acid B promotes bone fusion by angiogenesis and osteogenesis in a rat spinal fusion model10.1016/j.biomaterials.2018.04.004 ↗
22. PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits10.1016/j.actbio.2013.01.024 ↗
23. Improved dimensional stability with bioactive glass fibre skeleton in poly(lactide-co-glycolide) porous scaffolds for tissue engineering10.1016/j.msec.2015.07.013 ↗
24. Poly(lactic-co-glycolic acid)-bioactive glass composites as nanoporous scaffolds for bone tissue engineering: in vitro and in vivo studies
25. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
26. The in-vitro bioactivity of mesoporous bioactive glasses10.1016/j.biomaterials.2006.01.043 ↗
27. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors10.1016/j.jconrel.2014.04.026 ↗
28. Effects of incorporated vanadium and its chemical states on morphology and mesostructure of mesoporous bioactive glass particles10.1016/j.micromeso.2021.111061 ↗
29. Nanosized mesoporous bioactive glass/poly(lactic-co-glycolic acid) composite-coated CaSiO3 scaffolds with multifunctional properties for bone tissue engineering10.1155/2014/323046 ↗
30. Mesoporous bioactive glass/ϵ-polycaprolactone scaffolds promote bone regeneration in osteoporotic sheep10.1016/j.actbio.2019.04.019 ↗
31. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior
32. Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers10.1007/s00418-009-0629-6 ↗
33. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities10.1002/anie.200460598 ↗
34. Bio-inspired in situ crosslinking and mineralization of electrospun collagen scaffolds for bone tissue engineering10.1016/j.biomaterials.2016.07.007 ↗
35. Recent advances in bone tissue engineering scaffolds10.1016/j.tibtech.2012.07.005 ↗
36. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide)
37. One-pot synthesis of macro-mesoporous bioactive glasses/polylactic acid for bone tissue engineering10.1016/j.msec.2014.07.042 ↗
38. Fabrication and characterization of poly(D,L-lactide-co-glycolide)/hydroxyapatite nanocomposite scaffolds for bone tissue regeneration
39. Biodegradable polymer matrix nanocomposites for tissue engineering: a review
40. Anti-infective efficacy, cytocompatibility and biocompatibility of a 3D-printed osteoconductive composite scaffold functionalized with quaternized chitosan10.1016/j.actbio.2016.09.035 ↗
41. In vitro and in vivo degradation behavior of aqueous-derived electrospun silk fibroin scaffolds10.1016/j.polymdegradstab.2010.05.025 ↗
42. Bioactivity of gel-glass powders in the CaO-SiO2 system: a comparison with ternary (CaO-P2O5-SiO2) and quaternary glasses (SiO2-CaO-P2O5-Na2O)
43. Dose-dependent behavior of bioactive glass dissolution10.1002/jbm.10053 ↗
44. Enhancement of protein adsorption induced by surface roughness10.1021/la0621923 ↗
45. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds10.1016/j.biomaterials.2005.01.047 ↗
46. Effects of roughness, fibronectin and vitronectin on attachment, spreading, and proliferation of human osteoblast-like cells (Saos-2) on titanium surfaces10.1007/s002239900640 ↗
47. Bone morphogenetic proteins: relationship between molecular structure and their osteogenic activity10.1016/j.fshw.2014.12.002 ↗
48. RUNX/CBF transcription Factors☆
49. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro10.1016/j.bone.2007.04.191 ↗
50. The role of growth factors in the repair of bone biology and clinical applications
51. Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft10.1016/j.archoralbio.2004.05.012 ↗
52. Ion release behavior of vanadium-doped mesoporous bioactive glass particles and the effect of the released ions on osteogenic differentiation of BMSCs via the FAK/MAPK signaling pathway [J]10.1039/D1TB01479J ↗
53. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics10.1016/j.biomaterials.2011.01.004 ↗
54. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture10.1016/j.biomaterials.2005.01.006 ↗
55. The effect of silicate ions on proliferation, osteogenic differentiation and cell signalling pathways (WNT and SHH) of bone marrow stromal cells10.1039/C2BM00108J ↗
56. Angiogenesis assays for the evaluation of angiogenic properties of orthopaedic biomaterials – a general review10.1002/adhm.201600434 ↗